{"id":"https://openalex.org/W23338358","doi":null,"title":"ibogaine in the treatment of chemical dependence disorders: clinical perspectives","display_name":"ibogaine in the treatment of chemical dependence disorders: clinical perspectives","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W23338358","mag":"23338358"},"language":"en","primary_location":{"id":"mag:23338358","doi":null,"is_oa":false,"landing_page_url":"https://www.drugtext.org/pdf/Psychedelics/ibogaine-in-the-treatment-of-chemical-dependence-disorders-clinical-perspectives.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054428473","display_name":"Howard S. Lotsof","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Howard S. Lotsof","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5054428473"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4973,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.87117617,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.43529999256134033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.43529999256134033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.4214000105857849,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.06310000270605087,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibogaine","display_name":"ibogaine","score":1.0},{"id":"https://openalex.org/keywords/chemical-dependency","display_name":"chemical dependence","score":0.7839999794960022},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.5720000267028809},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.5860000252723694},{"id":"https://openalex.org/keywords/clinical-experience","display_name":"clinical experience","score":0.36000001430511475}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47228699922561646}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:23338358","doi":null,"is_oa":false,"landing_page_url":"https://www.drugtext.org/pdf/Psychedelics/ibogaine-in-the-treatment-of-chemical-dependence-disorders-clinical-perspectives.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W301132502","https://openalex.org/W1956616167","https://openalex.org/W1964308449","https://openalex.org/W1977439880","https://openalex.org/W1979641096","https://openalex.org/W1985177369","https://openalex.org/W2005327856","https://openalex.org/W2016346510","https://openalex.org/W2037778640","https://openalex.org/W2041742732","https://openalex.org/W2045711013","https://openalex.org/W2076964531","https://openalex.org/W2078969523","https://openalex.org/W2086448707","https://openalex.org/W2146563642","https://openalex.org/W2168575143","https://openalex.org/W2414357625","https://openalex.org/W2427363607"],"related_works":["https://openalex.org/W2604639035","https://openalex.org/W7165873302","https://openalex.org/W2784485362","https://openalex.org/W6903692511","https://openalex.org/W7098203099","https://openalex.org/W2026484120","https://openalex.org/W7120903997","https://openalex.org/W1584697855","https://openalex.org/W2077534208","https://openalex.org/W2201851578"],"abstract_inverted_index":{"The":[0,43],"primary":[1],"purpose":[2],"of":[3,70],"this":[4],"paper":[5],"is":[6,31,39],"to":[7,11,33],"provide":[8],"general":[9],"information":[10],"the":[12,18,71],"clinician":[13],"who":[14],"will":[15],"be":[16],"using":[17],"Lotsof":[19],"Proceduresm":[20],"(Goutarel,":[21],"1993)":[22],"developed":[23],"by":[24],"NDA":[25],"International,":[26],"Inc.":[27],"in":[28],"which":[29,47],"Ibogaine":[30],"administered":[32],"treat":[34],"chemical":[35],"dependence":[36],"disorders.":[37],"This":[38],"a":[40],"preliminary":[41],"report.":[42],"patient":[44],"base":[45],"upon":[46],"my":[48],"conclusions":[49],"have":[50,63],"been":[51,64],"made":[52,65],"totals":[53],"thirty-five":[54],"treatment":[55],"episodes.":[56],"All":[57],"clinical":[58],"observations":[59],"conducted":[60],"after":[61],"1963":[62],"on":[66],"patients":[67],"treated":[68],"outside":[69],"United":[72],"States.":[73]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2016-06-24T00:00:00"}